Related Experiment Video
Updated: Oct 11, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells
A Amore1, S N Emancipator, P Cirina
1Nephrology and Dialysis Department, Central Laboratory, Regina Margherita Children's Hospital, Torino, Italy. amorenefro@email.oirmsantanna.piemonte.it
Background:
The clinical use of cyclosporine (CsA) is limited by its nephrotoxicity. Apoptosis, perhaps instigated by increased nitric oxide synthase (NOS) activity, may play a role in such toxicity.
Methods:
Human mesangial cells, human tubular cells, human umbilical vein endothelial cells, or murine endothelial cells were cultured with CsA at final concentrations of 0 to 1000 ng/mL for 4 to 24 hours. As inhibitors of apoptosis, 0.01 mol/L L-nitromethylarginine (L-NAME) or 1 microg/mL cycloheximide (CHX) was added, whereas 0.01 mol/L sodium nitroprusside (as a nitric oxide donor) was used as a positive control. Apoptosis was assessed by using TUNEL method and by DNA fragmentation by electrophoresis. In addition, NOS enzymatic activity, Northern blots for inducible NOS (iNOS) mRNA, and immunohistochemically demonstrable iNOS protein were evaluated.
Results:
Within 12 to 24 hours, CsA significantly increased the fraction (8 to 35%) of apoptotic cells in each cell line, according to the dose. Fragmentation of DNA confirmed apoptosis. L-NAME and CHX inhibited the phenomenon, whereas sodium nitroprusside enhanced it. Each cell line significantly increased NOS activity in response to CsA, an effect blunted by L-NAME and CHX. Neither inhibitor modified the increased iNOS mRNA expression elicited by CsA. Positive staining for both iNOS and p53 proteins was observed in all cell lines incubated with CsA that were inhibited by CHX; L-NAME inhibited only p53 staining.
Conclusions:
CsA induces apoptosis in various renal cell lines, and this effect is mediated by the induction of iNOS via p53. These effects may contribute to the acellular fibrosis characteristic of late CsA nephrotoxicity.
Insights
Cyclosporine (CsA) causes kidney cell apoptosis by increasing nitric oxide synthase (NOS). Inhibiting NOS or p53 may prevent CsA-induced nephrotoxicity, potentially reducing fibrosis.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Biology
Background:
- Cyclosporine (CsA) use is limited by nephrotoxicity.
- Apoptosis, potentially mediated by nitric oxide synthase (NOS) activity, may contribute to CsA-induced kidney damage.
Purpose of the Study:
- To investigate the role of apoptosis and nitric oxide synthase (NOS) in cyclosporine (CsA)-induced nephrotoxicity.
- To examine the effects of CsA on apoptosis and NOS activity in various renal and endothelial cell lines.
Main Methods:
- Human and murine cell lines were treated with CsA (0-1000 ng/mL) for 4-24 hours.
- Apoptosis was assessed via TUNEL assay and DNA fragmentation.
- Nitric oxide synthase (NOS) activity, iNOS mRNA, and iNOS protein expression were evaluated, with and without apoptosis inhibitors L-nitromethylarginine (L-NAME) and cycloheximide (CHX).
Main Results:
- CsA significantly increased apoptosis in all cell lines in a dose-dependent manner.
- CsA elevated NOS activity, which was inhibited by L-NAME and CHX.
- CsA induced iNOS and p53 protein expression, with CHX inhibiting both and L-NAME inhibiting only p53.
Conclusions:
- Cyclosporine (CsA) induces apoptosis in renal cells through the induction of inducible nitric oxide synthase (iNOS) via p53.
- These findings suggest a mechanism for CsA nephrotoxicity and potential therapeutic targets.
More Related Videos
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Related Concept Videos
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators